BBSRC Portfolio Analyser
Award details
Studies on avian infectious bronchitis virus to underpin the development of stable advanced vaccines for more effective sustained control
Reference
BBS/E/I/00001256
Principal Investigator / Supervisor
Professor Paul Britton
Co-Investigators /
Co-Supervisors
Institution
The Pirbright Institute
Department
The Pirbright Institute Department
Funding type
Research
Value (£)
109,065
Status
Completed
Type
Institute Project
Start date
01/04/2006
End date
13/04/2010
Duration
48 months
Abstract
A report commissioned by Defra demonstrated that infectious bronchitis (IB) is not only a major cause of ill health amongst chickens, it is also responsible for more economic loss in the UK poultry industry than any other infectious disease. The current live vaccines that are used to partly control the disease are not genetically stable. We have a reverse genetic system, that enables us to make genetically stable modifications to the genome for vaccine development. Our previous research with this system has shown that IBV produces a number of proteins that are not essential for replication in vitro. Removal of the genes encoding these proteins might attenuate the pathogenicity of the virus. To test this hypothesis we need a pathogenic clone of IBV, our current clone being non-pathogenic. The major part of this project is a step-wise modification of our existing clone, introducing genes from a pathogenic strain to make chimaeras, followed by testing the pathogenicity of the chimaeras.
Summary
unavailable
Committee
Closed Committee - Animal Sciences (AS)
Research Topics
Animal Health, Immunology, Microbiology
Research Priority
X – Research Priority information not available
Research Initiative
X - not in an Initiative
Funding Scheme
X – not Funded via a specific Funding Scheme
I accept the
terms and conditions of use
(opens in new window)
export PDF file
back to list
new search